{"changes":[{"companyHref":"/c/verismotherapeutics-com","date":"2026-09-25","documentUrl":"https://www.sec.gov/Archives/edgar/data/1855431/000185543126000003/primary_doc.xml","domain":"verismotherapeutics.com","fact":"latest round","name":"Verismo Therapeutics, Inc.","new":{"amountUsd":28000000,"date":"2026-04-21","lead":null,"type":null},"old":{"amountUsd":28000000,"date":"2026-04-21","lead":null,"type":"seed"},"publisher":"SEC EDGAR","reason":null,"retrievedAt":"2026-09-25","slug":"verismotherapeutics-com","status":"sourced","url":"https://whoraisedwhat.com/c/verismotherapeutics-com"},{"companyHref":"/c/verismotherapeutics-com","date":"2026-09-25","documentUrl":"https://www.sec.gov/Archives/edgar/data/1855431/000185543126000003/primary_doc.xml","domain":"verismotherapeutics.com","fact":"provenance:round","name":"Verismo Therapeutics, Inc.","new":{"publisher":"SEC EDGAR","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/1855431/000185543126000003/primary_doc.xml"},"old":{"publisher":"sec-edgar","status":"attributed","url":null},"publisher":"SEC EDGAR","reason":null,"retrievedAt":"2026-09-25","slug":"verismotherapeutics-com","status":"sourced","url":"https://whoraisedwhat.com/c/verismotherapeutics-com"}],"country":"US","description":"Verismo Therapeutics develops CAR T cell therapies for solid tumors using its KIR-CAR (SynKIR) multi-chain immunoreceptor platform. It aims to treat patients whose solid tumors resist single-chain CAR T approaches. Modeled on NK-cell receptors, the construct reduces the T-cell exhaustion that limits earlier therapies.","domain":"verismotherapeutics.com","employees":null,"founded":2020,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"other health care","investors":[],"lat":39.952724,"lng":-75.163526,"location":"Philadelphia, PA","name":"Verismo Therapeutics, Inc.","rounds":[{"amountQuarantined":false,"amountUsd":28000000,"currency":"USD","date":"2026-04-21","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"SEC EDGAR","retrievedAt":"2026-09-25","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/1855431/000185543126000003/primary_doc.xml"},"status":"sourced","type":null,"url":"https://www.sec.gov/Archives/edgar/data/1855431/000185543126000003/primary_doc.xml"}],"slug":"verismotherapeutics-com","sources":[{"fact":"round","publisher":"SEC EDGAR","retrievedAt":"2026-09-25","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/1855431/000185543126000003/primary_doc.xml"},{"fact":"existence","publisher":"verismotherapeutics.com","retrievedAt":"2026-05-21","status":"self-reported","url":"https://verismotherapeutics.com"},{"fact":"description","publisher":"verismotherapeutics.com","retrievedAt":"2026-05-21","status":"self-reported","url":"https://verismotherapeutics.com"}],"stage":null,"techStack":["Cloudflare","WordPress","Yoast SEO 27.6","GoDaddy CoBlocks","Google Tag Manager","jQuery Migrate 3.4.1","parallax.js 1.5","PHP","Cloudflare Bot Management","OWL Carousel","web-vitals","MySQL"],"totalRaisedUsd":28000000,"updatedAt":"2026-05-21"}